Penicillamine Market

Penicillamine, sold under the trade names of Cuprimine, is a medication primarily used for the treatment of Wilson's disease. It is also used for people with kidney stones who have high urine cystine levels, rheumatoid arthritis, and various heavy metal poisonings. It is taken by mouth.
Penicillamine Market contains market size and forecasts of Penicillamine in global, including the following market information:
Global Penicillamine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Penicillamine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Penicillamine companies in 2021 (%)
The global Penicillamine market was valued at 85 million in 2021 and is projected to reach US$ 93 million by 2028, at a CAGR of 1.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Penicillamine include Bausch Health, Mylan, Novartis, Teva, Merck Sharp and Dohme, Taisho Seiyaku, Fresenius, Mitchells and Butlers and Biochem Chemopharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Penicillamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Penicillamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Penicillamine Market Segment Percentages, by Type, 2021 (%)
Tablet
Capsule
Global Penicillamine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Penicillamine Market Segment Percentages, by Application, 2021 (%)
Lead Poisoning
Wilson's Disease
Cystine Renal Calculi
Refractory Rheumatoid Arthritis
Severe Rheumatoid Arthritis
Global Penicillamine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Penicillamine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Penicillamine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Penicillamine revenues share in global market, 2021 (%)
Key companies Penicillamine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Penicillamine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Mylan
Novartis
Teva
Merck Sharp and Dohme
Taisho Seiyaku
Fresenius
Mitchells and Butlers
Biochem Chemopharma
Kendrick Labs
Panacea Pharma
UCB Pharma
IFET
DCC Plc